Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27851-27860 Newer>

The Motley Fool December 28, 2007 Anders Bylund	Luby's Digs in for a Proxy Pummeling Four out of ten board seats are up for election at the upcoming shareholders' meeting. Will a new board mean new progress for the restaurant chain?
The Motley Fool December 28, 2007 Rick Aristotle Munarriz	Next Stop: Microhoo! Over the past two months, Google has grown more dominant at the expense of a fading Yahoo!, leading to speculation that Yahoo! and Microsoft should merge before Google gets any bigger.
The Motley Fool December 28, 2007 Rich Smith	United Tech's $12 Billion Crickets The market reacts very quietly to news that the Defense Department has awarded United Technologies a $1.5 billion contract to build Black Hawk and Medevac helicopters.
The Motley Fool December 28, 2007 Brian Orelli	The Biggest Health-Care IPOs of 2007 Let's take a look at four of the most intriguing health care IPOs from 2007.
The Motley Fool December 28, 2007 Brian Orelli	Investing in a Purchased Company Billionaire investor Steven Cohen, through his hedge fund SAC Capital Advisors, ups his stake in biotech company Pharmion. Let's take a look at why.
The Motley Fool December 28, 2007 Sham Gad	China's Stock Market Alphabet Confused by all the different share classes of Chinese companies? Here's some help.
The Motley Fool December 28, 2007 Rich Smith	Remington Outdraws the Competition The gunsmith aims to distance itself even further from the pack, with its purchase of Marlin Firearms.
The Motley Fool December 28, 2007 Austin Edwards	This Mistake Could Cost You a Fortune While investors may never agree on when or why to sell a stock, it's important to have an emotionless, well-thought-out strategy in place. If you don't, you may suffer major losses or miss out on massive gains.
The Motley Fool December 28, 2007 Selena Maranjian	Invest Like Harvard and Yale Many foreign economies have been booming in recent years, so don't neglect foreign investments in your portfolio.
The Motley Fool December 27, 2007 Brian Orelli	Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there.
<Older 27851-27860 Newer> Return to current articles.